GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

American Healthcare REIT AHR · USD

Real Estate · US listing · 🇺🇸 United States

Compare

58.96

+1.81%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$285.2m

FY2016FY2025

Net income

−$5.9m

FY2016FY2025

Free cash flow

−$26.3m

FY2016FY2025

Shareholders' equity

$627.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$285.2m$274.1m$253.9m$454.2m$284.1m$383.6m$257.2m$193.3m$302.8m$258.4m
Operating income$81.3m$78.2m$60.5m$64.5m$43.2m$43.6m$39.0m$29.7m$32.5m$28.6m
Net income−$5.9m$24.1m−$3.3m$63.2m$10.3m$21.8m$21.6m$17.2m$21.0m$28.1m
Diluted earnings per share-0.070.34-0.040.940.170.380.410.270.350.56

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$2.60bn$2.51bn$2.56bn$2.24bn$1.94bn$1.92bn$1.80bn$1.27bn$1.04bn$982.5m
Cash and short-term investments$49.1m$70.6m$27.9m$48.1m$35.2m$41.0m$39.2m$21.3m$20.0m$21.9m
Total liabilities$1.97bn$1.84bn$1.99bn$1.59bn$1.38bn$1.39bn$1.40bn$991.5m$816.4m$834.3m
Debt$1.62bn$1.39bn$1.49bn$1.11bn$963.7m$981.8m$968.4m$694.2m$517.3m$522.2m
Shareholders' equity$627.8m$670.6m$572.6m$647.5m$555.4m$523.2m$408.6m$273.9m$226.7m$148.1m
Shares outstanding80m71m68m68m61m57m53m65m60m50m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$64.2m$112.0m$93.3m$116.9m$91.2m$91.2m$67.7m$56.1m$51.2m$57.0m
Capital spending−$90.5m−$60.2m−$91.8m−$213.0m−$137.7m−$108.7m−$291.5m−$203.1m−$88.0m−$259.8m
Free cash flow−$26.3m$51.8m$1.5m−$96.1m−$46.5m−$17.5m−$223.8m−$147.0m−$36.8m−$202.8m
Dividends paid−$75.2m−$83.9m−$80.4m−$72.6m−$58.7m−$47.6m−$61.5m−$50.9m−$43.6m−$33.8m

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
Revenue−$26.8m$96.1m$101.3m$114.6m$142.6m$187.7m$184.7m$193.5m
Operating income$20.2m$23.6m$20.3m$17.2m$18.4m$25.0m$25.6m$23.5m
Net income−$507,000−$2.8m$3.1m−$5.7m$20.6m−$7.9m$285,000$11.2m
Diluted earnings per share—-0.040.04-0.070.26-0.120.000.17
Cash from operations$26.0m$26.0m$11.0m—$20.0m$27.0m$17.0m$46.0m
Capital spending−$46.0m−$16.0m−$10.0m−$16.0m−$14.0m−$15.0m−$7.0m−$23.0m
Free cash flow−$20.0m$10.0m$1.0m—$6.0m$12.0m$10.0m$23.0m
Total assets$2.60bn$2.58bn$2.58bn$2.47bn$2.51bn$2.56bn$2.57bn$2.60bn
Cash and short-term investments$49.1m$46.5m$52.1m$45.7m$70.6m$43.9m$20.3m$41.9m
Debt$1.20bn$1.55bn$1.51bn$1.28bn$1.25bn$1.42bn$1.48bn$1.45bn
Shareholders' equity$627.8m$638.8m$652.0m$657.4m$670.6m$663.9m$562.7m$571.4m

Financial ratios

Data as of 6 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin5.9%4.5%4.7%2.1%0.4%2.8%———
Net margin3.1%-1.8%-3.8%-5.0%-3.8%0.2%———
Return on equity2.1%-1.7%-5.6%-5.8%-3.0%0.2%———
Return on assets1.3%-0.8%-1.6%-1.7%-1.0%0.1%———
Free cash flow yield5.0%3.5%5.9%6.6%2.9%15.3%———
Revenue growth9.1%11.4%14.9%28.0%6.7%-3.0%———
Earnings growth-284.6%-47.1%-12.1%70.1%-2309.6%-143.6%———
Current ratio0.37x0.37x0.20x0.61x0.30x1.83x———
Debt to equity0.47x0.75x2.20x1.14x1.30x1.91x———
Equity ratio61.2%50.4%27.7%29.2%34.5%26.8%———
Interest coverage1.57x0.73x0.53x0.31x0.07x0.46x———
R&D as a share of sales——0.0%0.0%0.0%—0.0%0.0%0.0%
Buybacks as a share of market value-8.6%-132.7%0.1%-0.8%-45.8%75.3%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-14.4%-5.8%1.2%
Operating income8.0%13.3%11.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin28.5%22.5%19.2%16.6%
Net margin3.2%6.2%5.7%6.8%

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings-634.383.3
Price to sales13.27.3

Market value over time

29 Feb 2024 to 5 Oct 2026, in USD

$902.2m$9.63bn

Share price return

Finished calendar years

20252024
Return74%107%

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 30 Sept 2026.

FY2026FY2025FY2024
Paid in the year0.751.001.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.